Agios Pharmaceuticals (AGIO)
(Delayed Data from NSDQ)
$33.00 USD
+0.08 (0.24%)
Updated May 10, 2024 04:00 PM ET
After-Market: $33.03 +0.03 (0.09%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.59 |
EPS Last Quarter | -1.45 |
Last EPS Surprise | 11.59% |
ABR | 1.78 |
Earnings ESP
|
1.05% |
---|---|
Current Year | -4.66 |
Next Year | -5.68 |
EPS (TTM) | -6.32 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.72M | 48.80M | 120.40M | 92.87M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 14.91M | 200.90M | 237.80M | 160.76M |
Low Estimate | 7.50M | 7.80M | 30.50M | 63.80M |
Year ago Sales | 6.71M | 7.40M | 26.82M | 120.40M |
Year over Year Growth Est. | 44.89% | 559.46% | 348.88% | -22.87% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.59 | -0.91 | -4.66 | -5.68 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | -1.69 | 1.64 | -6.89 | -6.54 |
High Estimate | -1.45 | 1.64 | -2.82 | -4.31 |
Low Estimate | -1.69 | -1.59 | -6.89 | -6.54 |
Year ago EPS | -1.51 | -1.64 | -6.33 | -4.66 |
Year over Year Growth Est. | -5.30% | 44.51% | 26.38% | -21.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 2 | 2 |
Up Last 30 Days | 2 | 2 | 5 | 5 |
Up Last 60 Days | 2 | 2 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.59 | -0.91 | -4.66 | -5.68 |
7 Days Ago | -1.60 | -0.91 | -4.75 | -5.76 |
30 Days Ago | -1.63 | -1.56 | -5.28 | -5.88 |
60 Days Ago | -1.63 | -1.56 | -5.28 | -5.88 |
90 Days Ago | -1.58 | -1.51 | -5.00 | -5.41 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.58 | 0.10 | -4.98 | -5.85 |
Zacks Consensus Estimate | -1.59 | -0.91 | -4.66 | -5.68 |
Earnings ESP | 1.05% | 110.39% | -6.97% | -3.07% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.45 | -1.72 | -1.64 | -1.51 | NA |
Estimate | -1.64 | -1.64 | -1.69 | -1.60 | NA |
Difference | 0.19 | -0.08 | 0.05 | 0.09 | 0.06 |
Surprise | 11.59% | -4.88% | 2.96% | 5.63% | 3.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more